60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response

<strong>Objective:</strong> A recent meta-regression had shown that the degree of placebo response, which has increased over the decades, is the major predictor of drug-placebo differences in antipsychotic drug trials in acutely ill patients with schizophrenia. Drug response, however, ha...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Leucht, S, Chaimani, A, Leucht, C, Huhn, M, Mavridis, D, Helfer, B, Samara, M, Cipriani, A, Geddes, JR, Salanti, G, Davis, JM
Formáid:	Journal article
Foilsithe / Cruthaithe:	Elsevier 2018

Míreanna comhchosúla

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2019)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors.
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2017)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2017)

Efficacy of antipsychotic drugs for schizophrenia - Authors' reply.
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2013)

Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2018)

Initial Severity of Schizophrenia and Efficacy of Antipsychotics: Participant-Level Meta-analysis of 6 Placebo-Controlled Studies.
de réir: Furukawa, T, et al.
Foilsithe / Cruthaithe: (2015)

The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia.
de réir: Spineli, L, et al.
Foilsithe / Cruthaithe: (2013)

The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia
de réir: Spineli, L, et al.
Foilsithe / Cruthaithe: (2013)

Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article
de réir: Chaimani, A, et al.
Foilsithe / Cruthaithe: (2017)

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2013)

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2013)

Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy.
de réir: Furukawa, T, et al.
Foilsithe / Cruthaithe: (2018)

Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies
de réir: Samara, MT, et al.
Foilsithe / Cruthaithe: (2017)

DSM-III-R change in definition might have affected placebo response to antidepressants - Authors' reply
de réir: Cipriani, A, et al.
Foilsithe / Cruthaithe: (2017)

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
de réir: Furukawa, T, et al.
Foilsithe / Cruthaithe: (2016)

Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis
de réir: Salanti, G, et al.
Foilsithe / Cruthaithe: (2018)

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
de réir: Huhn, M, et al.
Foilsithe / Cruthaithe: (2019)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
de réir: Maximilian Huhn, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Network meta-analyses should be the highest level of evidence in treatment guidelines
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2016)

Commentary on strategies for switching antipsychotics
de réir: Leucht Stefan, et al.
Foilsithe / Cruthaithe: (2008-06-01)

Authors' reply
de réir: Leucht, S, et al.
Foilsithe / Cruthaithe: (2013)

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis
de réir: Spyridon Siafis, et al.
Foilsithe / Cruthaithe: (2020-08-01)

An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios.
de réir: Efthimiou, O, et al.
Foilsithe / Cruthaithe: (2014)

An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios
de réir: Efthimiou, O, et al.
Foilsithe / Cruthaithe: (2014)

Comparative efficacy and tolerability of 31 oral and long-acting injectable antipsychotics for maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
de réir: Schneider-Thoma, J, et al.
Foilsithe / Cruthaithe: (2022)

Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review
de réir: Furukawa, T, et al.
Foilsithe / Cruthaithe: (2016)

The treatment of schizophrenia - the state of the evidence
de réir: Leucht Stefan
Foilsithe / Cruthaithe: (2008-04-01)

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
de réir: Geddes, J, et al.
Foilsithe / Cruthaithe: (2000)

Are the results of open randomised controlled trials comparing antipsychotic drugs in schizophrenia biased? Exploratory meta- and subgroup analysis
de réir: Stefan Leucht, et al.
Foilsithe / Cruthaithe: (2024-02-01)

The implications of relapses on the evolution of schizophrenia. How to prevent them?
de réir: Leucht Stefan
Foilsithe / Cruthaithe: (2006-02-01)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
de réir: Georgia Salanti, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
de réir: Johannes Schneider-Thoma, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
de réir: Stephen Z. Levine, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Atypical antipsychotics in the treatment of schizophrenia: Systematic review, meta-regression and evidence-based treatment recommendations
de réir: Geddes, J, et al.
Foilsithe / Cruthaithe: (2000)

Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
de réir: Ogawa, Y, et al.
Foilsithe / Cruthaithe: (2017)

New generation versus conventional antipsychotics [3] (multiple letters)
de réir: Geddes, J, et al.
Foilsithe / Cruthaithe: (2003)

Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe.
de réir: Fleischhacker, W, et al.
Foilsithe / Cruthaithe: (2002)

Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.
de réir: Spineli, L, et al.
Foilsithe / Cruthaithe: (2013)

Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews
de réir: Tamara Melnik, et al.

Allowing for uncertainty due to missing and LOCF imputed outcomes in meta‐analysis
de réir: Mavridis, D, et al.
Foilsithe / Cruthaithe: (2018)